Myriad Genetics (MYGN) – FDA
-
Myriad Genetics (MYGN) Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing
-
Myriad Genetics (MYGN) and Personalis Partner to Market Solutions to Pharma Customers
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MYGN Stock Lookup